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Abstract: Novel derivatives of 6-amino-2-phenylbenzothiazole bearing different 
substituents (amino, dimethylamino or fluoro) on the phenyl ring were prepared as the 
corresponding hydrochloride salts. 6-Nitro-2-(substituted-phenyl)benzothiazoles (1-6) were 
synthesized by condensation reactions of substituted benzaldehydes with 2-amino-5-
nitrothiophenol. Nitro derivatives were reduced to the amino derivatives with SnCl2/HCl. 
Water soluble hydrochloride salts of 6-amino-2-(substituted-phenyl)benzothiazole (13-19) 
were prepared using concentrated or gaseous HCl. Compounds 13-19 were found to exert 
cytostatic activities against malignant human cell lines: cervical (HeLa), breast (MCF-7), 
colon (CaCo-2), laryngeal carcinoma (Hep-2), and normal human fibroblast cell lines (WI-
38).  
 
Keywords: Benzothiazole synthesis, antitumor activity. 
 
 
Introduction 
The study of benzothiazole derivates is of considerable current interest as a result of their 
important biological and biophysical properties. 2-Aryl or 2-heteroaryl substituted benzothiazoles are 
studied as antitumor [1], antimicrobial [2], antifungal [3] agents, as well as imaging agents for β-
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amyloid [4]. A series of potent and selective antitumor agents derived from 2-(4-
aminophenyl)benzothiazole was extensively examined and developed during recent years and the 
fluorinated analogue, 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole is a novel agent with potent 
and selective antitumor properties which in the form of its L-lysylamide prodrug, Phortress, is in early 
phase clinical studies [5]. 
 In connection with our studies on the synthesis and biological properties of substituted 
benzothiazoles [6-8] we turned our attention to the synthesis and antitumor evaluation of novel 2-
(substituted-phenyl)-6-aminobenzothiazole as analogous of 2-(4-aminophenyl)benzothiazole prepared 
as hydrochloride or dihydrochloride salts. 
 
Results and Discussion  
 
Synthesis 
 
An efficient synthesis of 2-phenylbenzothiazole derivatives was carried out by the reactions 
outlined in Scheme 1. 
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Starting from 2-amino-5-nitrothiophenol (freshly prepared by basic hydrolysis of 6-
nitrobenzothiazole) and the corresponding aromatic aldehyde 6-nitro-2-(monosubstituted phenyl)-
benzothiazoles 1-6 were obtained in moderate yield (40-70%) by condensation in pyridine (procedure 
A). The reduction of nitro compounds was accomplished with SnCl2 in methanol-HCl mixtures in a 
short time at reflux giving the desired 6-amino-2-phenylbenzothiazole derivatives 7-12 in good yields 
of 70-80% (procedure B). Treating the solutions of amines 10-11 or diamines 7-9, dissolved in a 
mixture of abs. ethanol and xylene (1:1, v/v) with concd. hydrochloric acid (procedure C) the 
corresponding amines were protonated and isolated as pure hydrochlorides 13-17, 19 in excellent 
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yields (91-99%) without recrystallization. The same products can be obtained in similar yields by 
treating the amines with gaseous HCl (procedure D). Only for 6-amino-2-(3-fluorophenyl)-
benzothiazole (11) was selective preparation of the monohydrochloride salt 17 (procedure C) and the 
dihydrochloride salt 18 (procedure D), in which protonation occurs on both the amino and 
benzothiazole nitrogens possible. The structures of new compounds 1-19 were confirmed by elemental 
analysis and spectral data (IR, NMR). Due to a very low solubility of nitro compounds 2 and 3, only 
elemental analysis, and IR spectra were recorded. 
 
Biological Activity 
 
The effects of the seven water soluble compounds 13-19 were tested on the human malignant cell 
lines: cervical (HeLa), breast (MCF-7), colon (CaCo-2), laryngeal carcinoma (Hep-2) and normal 
human fibroblast cell lines (WI-38). Inhibitory effects are shown in Table 1.  
 
Table 1. 
Comp.   IC50 (M)   
No.    HeLa CaCo-2   HEP-2  MCF7   WI-38 
13 6×10
-4 4×10-3 9×10-5 6×10-4 4×10-3 
14 3×10
-3 8×10-4 4×10-5 7×10-5 4×10-5 
15 9×10
-5 1×10-4 2×10-5 6×10-5 7×10-3 
16 4×10
-3 8×10-4 5×10-5 2×10-4 7×10-5 
17 8×10
-5 9×10-5 2×10-5 4×10-5 4×10-4 
18 9×10
-5 1×10-4 3×10-5 3×10-5 7×10-5 
19 5×10
-5 3×10-4 9×10-6 4×10-5 8×10-5 
 
All benzothiazoles tested exhibited moderate antitumour activity with IC50 values ranging from 
9×10-6 to 4×10-3 M. Most sensitive cell lines were HEP-2 and MCF-7. Our results showed up that 
activity of the compounds investigated decreasing from ortho- meta- to para- position (p < 0.05) the 
fluoro substituted benzothiazoles 17, 18 and 19 being more active. 
 
Experimental  
 
General 
 
Melting points were determined on a Kofler hot stage microscope and are uncorrected. IR spectra 
were recorded on a Nicolet Magna 760 spectrophotometer in KBr discs. 1H- and 13C-NMR spectra 
were recorded on either a Varian Gemini 300 or a Brucker Avance DPX 300 spectrometer. Chemical 
shifts (δ) are reported in parts per million (ppm) relative to tetramethylsilane (TMS) as an internal 
standard, and coupling constants (J) are given in hertz (Hz). Elemental analyses were carried out in the 
Microanalitical laboratory at the Rugjer Boskovic Institute. All compounds were routinely checked by 
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TLC with Merck silica gel 60F-254 glass plates. 2-Amino-5-nitrothiophenole was prepared according 
to the procedure described for preparation of 2-amino-5-cyanothiophenole [9] from 6-nitro-
benzothiazole. 
 
Synthesis of 6-nitro-2-(substituted-phenyl)benzothiazoles 1-6 
 
Procedure A: To a boiling solution of the appropriate substituted benzaldehyde (0.02 mol) in 
pyridine (20 mL), a solution of 2-amino-5-nitrothiophenole (0.02 mol) in pyridine (20 mL) was added 
dropwise, and the stirred reaction mixture was refluxed for 20 h. The mixture was then poured into 300 
ml of 2 M hydrochloric acid and after cooling overnight the obtained crystalline product was filtered 
off and crystallized from appropriate solvent. Using this procedure the following compounds were 
prepared. 
 
6-Nitro-2-(2-nitrophenyl)benzothiazole (1). Yield: 40.0% after crystallisation from xylene; mp 164-
165°C; IR cm-1: 1569, 1517, 1348, 842, 756, 749, 721; 1H-NMR (DMSO-d6) δ: 9.33 (d, 1H, J = 2.0 
Hz), 8.40 (dd, 1H, J = 2.0 Hz, J = 8.9 Hz), 8.26 (d, 1H, J = 8.9 Hz), 8.16 (d, 1H, J = 8.3 Hz), 8.06 (d, 
1H, J = 8.1 Hz), 7.96-7.87 (m, 2H); Anal. Calcd. for C13H7N3O4S: C, 51.83; H, 2.34; N, 13.95; Found: 
C, 51.68; H, 2.40; N, 14.03.  
 
6-Nitro-2-(3-nitrophenyl)benzothiazole (2). Yield:  70.9% (from xylene); mp 214-215 °C; IR cm-1: 
1601, 1538, 1514, 1340, 829, 752, 739, 720; Anal. Calcd. for C13H7N3O4S: C, 51.83; H, 2.34; N, 13.95; 
Found: C, 51.99; H, 2.11; N, 13.90. 
 
6-Nitro-2-(4-nitrophenyl)benzothiazole (3) Yield: 67.1% (from xylene); mp 256-257 °C; IR cm-1: 1606, 
1517, 1346, 854, 754, 719; Anal. Calcd. for C13H7N3O4S: C, 51.83; H, 2.34; N, 13.95; Found: C, 51.92; 
H, 2.29; N, 13.88.  
 
6-Nitro-2-(4-N,N-dimethylaminophenyl)benzothiazole (4). Yield:  66.1% (from xylene); mp 262-263 
°C; IR cm-1: 1610, 1594, 1474, 1434, 1330, 810, 752; 1H-NMR (DMSO-d6) δ: 9.09 (s, 1H), 8.30 (d, 
1H, J = 9.0 Hz), 8.05 (d, 1H, J = 9.0 Hz), 7.96 (d, 2H, J = 8.8 Hz), 6.85 (d, 2H, J = 8.8 Hz), 3.05 (s, 
12H); Anal. Calcd for C15H13N3O2S: C, 60.18; H, 4.38; N, 14.04; Found: C, 60.41; H, 4.44; N, 14.30. 
 
6-Nitro-2-(3-fluorophenyl)benzothiazole (5). Yield:  45.7% (from toluene); mp 199-200 °C; IR cm-1: 
1588, 1515, 1448, 1343, 809, 785, 753; 1H-NMR (DMSO-d6) δ: 9.24 (d, 1H, J = 2.1 Hz), 8.35 (dd, 1H, 
J = 8.9 Hz, J = 2.3 Hz), 8.24 (d, 1H, J = 8.9 Hz), 7.99-7.93 (m, 2H), 7.65 (m, 1H), 7.49 (m, 1H); Anal. 
Calcd. for C13H7FN2O2S: C, 56.93; H, 2.57; N, 10.21; Found: C, 57.20; H, 2.63; N, 10.00. 
 
6-Nitro-2-(4-fluorophenyl)benzothiazole (6). Yield: 58.2% (from xylene); mp 183-185 °C; IR cm-1: 
1592, 1510, 1474, 1334, 839, 751; 1H-NMR (DMSO-d6) δ: 9.23 (d, 1H, J = 2.4 Hz), 8.36 (dd, 1H, J = 
8.9 Hz, J = 2.4 Hz), 8.25-8.20 (m, 3H), 7.46 (dd, 2H, J = 8.8 Hz, J = 10.8 Hz); 13C-NMR (DMSO-d6) 
δ: 172.6, 164.6 (d, J = 251 Hz), 157.4, 144.6, 135.4, 130.4 (d, J = 9.3 Hz, 2C), 129.0, 123.3, 122.1, 
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119.7, 116.8 (d, J = 22.4 Hz, 2C); Anal. Calcd for C13H7FN2O2S: C, 56.93; H, 2.57; N, 10.21; Found: 
C, 56.74; H, 2.65; N, 10.02. 
 
Synthesis of 6-amino-2-(substituted-phenyl) benzothiazoles 7-12 
 
Procedure B: A solution of tin(II) chloride dihydrate (9 g, 0.04 mol), concd. HCl (18 mL) and 
methanol (18 mL) was added to the appropriate 6-nitro-2-(nitrophenyl)benzothiazole 1-3 (0.005 mol), 
or 0.01 mol of the compounds 4-6. The mixture was stirred and refluxed for 15 min. Methanol was 
removed by vacuum evaporation and the residue was dissolved in water. After basification to pH > 9 
with 20% NaOH the product was extracted with ether and dried (MgSO4). The solvent was removed 
under reduced pressure and the white solid obtained was crystallised from the appropriate solvent. The 
following compounds were prepared by thus method: 
 
6-Amino-2-(2-aminophenyl)benzothiazole (7). Yield: 74.5% (after crystallisation from toluene); mp 
185-187 °C; IR cm-1: 3438, 3351, 3299, 1611, 1487, 817, 754; 1H-NMR (DMSO-d6) δ: 7.62 (d, 1H, J 
= 8.6 Hz), 7.47 (d, 1H, J = 7.6 Hz), 7.13 (s, 2H), 7.10 (d, 1H, J = 8.0 Hz), 7.04 (s, 1H), 6.79 (d, 1H, J 
= 8.3 Hz), 6.72 (m, 1H), 6.58 (m, 1H, J = 7.5 Hz), 5.42 (s, 2H); Anal. Calcd for C13H11N3S: C, 64.70; 
H, 4.59; N, 17.41; Found: C, 64.83; H, 4.63; N, 17.29. 
 
6-Amino-2-(3-aminophenyl)benzothiazole (8). Yield: 68.2% (from xylene); mp 202-205 °C; IR cm-1: 
3406, 3300, 3200, 1621, 1602, 1485, 815, 788; 1H-NMR (DMSO-d6) δ: 7.62 (d, 1H, J = 8.6 Hz), 7.19 
(s, 1H), 7.13-7.02 (m, 3H), 6.74 (d, 1H, J = 8.6 Hz), 6.62 (d, 1H, J = 7.6 Hz), 5.44 (s, 2H), 5.35 (s, 
2H); 13C-NMR (DMSO-d6) δ: 161.4, 149.2, 147.2, 145.1, 136.0, 134.0, 129.5, 122.9, 115.7, 114.9, 
114.0, 111.3, 103.7; Anal. Calcd for C13H11N3S: C, 64.70; H, 4.59; N, 17.41; Found: C, 64.75; H, 4.42; 
N, 17.38. 
 
6-Amino-2-(4-aminophenyl)benzothiazole (9). Yield: 68.8% (toluene); mp 263-265 °C; IR cm-1: 3456, 
3365, 3304, 3193, 1621, 1606, 1488, 822; 1H-NMR (DMSO-d6) δ: 7.74 (d, 2H, J = 8.3 Hz), 7.67 (d, 
1H, J = 8.6 Hz), 7.14 (s, 1H), 6.83 (d, 2H, J = 8.3 Hz), 5.84 (s, 2H), 5.43 (s, 2H); 13C-NMR (DMSO-
d6) δ: 161.6, 151.0, 146.4, 145.4, 135.3, 127.8 (2C), 122.0, 120.9, 114.4, 113.5 (2C), 104.0; Anal. 
Calcd for C13H11N3S: C, 64.70; H, 4.59; N, 17.41; Found: C, 64.58; H, 4.50; N, 17.62. 
 
6-Amino-2-(4-N,N-dimethylaminophenyl)benzothiazole (10). Yield: 68.7% (from xylene); mp 230-
233°C; IR cm-1: 3459, 3306, 3188, 1610, 1489, 813; 1H-NMR (DMSO-d6) δ: 7.78 (d, 2H, J = 8.9 Hz), 
7.60 (d, 1H, J = 8.6 Hz), 7.07 (d, 1H, J = 2.1 Hz), 6.81 (d, 2H, J = 8.9 Hz), 6.75 (dd, 1H, J = 2.1 Hz, J 
= 8.6 Hz), 5.36 (s, 2H), 3.02 (s, 6H); 13C-NMR (DMSO-d6) δ: 161.4, 151.4, 146.5, 145.4, 135.4, 127.5 
(2C), 122.2, 120.9, 114.5, 111.8 (2C), 104.0, 39.7 (2C); Anal. Calcd for C15H15N3S: C, 66.88; H, 5.61; 
N, 15.60; Found: C, 66.95; H, 5.72; N, 15.52. 
 
6-Amino-2-(3-fluorophenyl)benzothiazole (11). Yield: 74.6% (toluene-petroleum ether, 1:1, v/v); mp 
127-128 °C; IR cm-1: 3408, 3312, 3218, 1602, 1442, 852, 827, 793; 1H-NMR (DMSO-d6) δ: 7.76-7.68 
(m, 3H), 7.54 (m, 1H), 7.31 (m, 1H), 7.08 (s, 1H), 6.79 (d, 1H, J = 8.6 Hz), 5.57 (s, 2H); 13C-NMR 
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(DMSO-d6) δ: 162.4 (d, J = 244 Hz), 158.7, 147.8, 144.9, 136.5, 135.6 (d, J = 8.2 Hz), 131.3 (d, J = 
8.4 Hz), 123.4, 122.6 (d, J = 2.6 Hz), 116.8 (d, J = 21.0 Hz), 115.3, 112.5 (d, J = 23.0 Hz), 103.5. 
Anal. Calcd for C13H9FN2S: C, 63.92; H, 3.71; N, 11.47; Found: C, 63.73; H, 3.80; N, 11.52. 
 
6-Amino-2-(4-fluorophenyl)benzothiazole (12). Yield: 79.3% (from toluene-petroleum ether, 1:1, v/v); 
mp 156-157 °C; IR cm-1: 3407, 3314, 3218, 1606, 1487, 839, 827, 801; 1H-NMR (DMSO-d6) δ: 7.97 
(dd, 2H, J = 8.6 Hz, J = 5.3 Hz), 7.66 (d, 1H, J = 8.6 Hz), 7.33 (dd, 2H, J = 8.6 Hz, J = 10.3 Hz), 7.07 
(s, 1H), 6.77 (d, 1H, J = 8.6 Hz), 5.50 (s, 2H); 13C-NMR (DMSO-d6) δ: 163.2 (d, J = 247 Hz), 159.3, 
147.6 145.2, 136.5, 130.2, 128.7 (d, J = 7.7 Hz), 123.3, 116.3 (d, J = 21.8 Hz), 115.3, 103.8; Anal. 
Calcd for C13H9FN2S: C, 63.92; H, 3.71; N, 11.47; Found: C, 63.78; H, 3.85; N, 11.55. 
 
Synthesis of amine hydrochloride salts 13-19. 
 
Procedure C: The amines 7-12 (0.005 mol) were dissolved in a warm mixture of ethanol and 
xylene (1:1, v/v) followed by the addition of concd. HCl (1.0 mL). The contents were stirred in a 
stoppered flask for 4 h. The precipitated pure crystals were collected by filtration, washed with dry 
ether, and dried in vacuo. The following compounds were prepared by this method: 
 
6-Amino-2-(2-aminophenyl)benzothiazole dihydrochloride (13). Yield: 96.6%; mp 224-227 °C; IR 
cm-1: 2816, 2662, 2524, 1486, 1463, 980, 767; 1H-NMR (DMSO-d6) δ: 8.11 (s, 1H), 8.07 (d, 1H, J = 
8.6 Hz), 7.64 (d, 1H, J = 8.0 Hz), 7.49 (d, 1H, J = 8.6 Hz), 7.24 (dd, 1H, J = 8.0 Hz, J = 7.3 Hz), 6.29 
(d, 1H, J = 8.3 Hz), 6.69 (dd, 1H, J = 7.7 Hz, J = 7.3), 4.78 (br s); 13C-NMR (DMSO-d6) δ: 169.6, 
152.7, 144.2, 133.7, 132.3, 130.4, 129.2 (2C), 123.2, 122.3, 118.8, 117.1, 115.7; Anal. Calcd for 
C13H13Cl2N3S: C, 49.69; H, 4.18; N, 13.37; Cl, 22.56; Found: C, 49.55; H, 4.15; N, 13.37; Cl, 22.38. 
 
6-Amino-2-(3-aminophenyl)benzothiazole dihydrochloride (14). Yield: 97.4%; mp 253-255 °C; IR 
cm-1: 2896, 2605, 1595, 1521, 1456, 818, 786; 1H-NMR (DMSO-d6) δ: 8.05 (d, 1H, J = 8.6 Hz), 7.97 
(s, 1H), 7.88 (s, 1H), 7.80 (d, 1H, J = 7.7 Hz), 7.53 (dd, 1H, J = 8.0 Hz, J = 7.7 Hz), 7.40 (d, 1H, J = 
8.8 Hz), 7.32 (d, 1H, J = 7.7 Hz); 13C-NMR (DMSO-d6) δ: 167.2, 152.4, 135.5, 134.3, 133.8, 131.0, 
130.5, 126.1, 125.8, 124.0, 122.2, 121.1, 116.9; Anal. Calcd for C13H13Cl2N3S: C, 49.69; H, 4.18; N, 
13.37; Cl, 22.56; Found: C, 49.70; H, 4.10; N, 13.35; Cl, 22.63. 
 
6-Amino-2-(4-aminophenyl)benzothiazole dihydrochloride (15). Yield: 99.3%; mp 247-248 °C; IR 
cm-1: 2852, 2554, 1605, 1507, 1485, 974, 822; 1H-NMR (DMSO-d6) δ: 7.95-7.92 (m, 2H), 7.79 (d, 2H, 
J = 8.7 Hz), 7.36 (d, 1H, J = 8.3 Hz), 6.76 (d, 2H, J = 8.7 Hz), 4.41 (br s); 13C-NMR (DMSO-d6) δ: 
168.5, 152.7, 143.5, 135.1 (2C), 129.4 (2C), 128.9, 126.1, 123.2, 122.0, 119.4, 116.9; Anal. Calcd for 
C13H13Cl2N3S: C, 49.69; H, 4.18; N, 13.37; Cl, 22.56; Found: C, 49.68; H, 4.06; N, 13.37; Cl, 22.64. 
 
6-Amino-2-(4-N,N-dimethylaminophenyl)benzothiazole dihydrochloride (16). Yield: 99.5%; mp 240-
242 °C; IR cm-1: 2796, 2568, 2453, 1607, 1519, 841; 1H-NMR (DMSO-d6) δ: 8.06 (s, 1H), 7.99 (d, 1H, 
J = 8.6 Hz), 7.89 (d, 2H, J = 8.9 Hz), 7.44 (d, 1H, J = 8.6 Hz), 6.85 (d, 2H, J = 8.9 Hz), 3.01 (s, 6H); 
13C-NMR (DMSO-d6) δ: 169.8, 152.0, 150.2, 134.5, 128.9 (2C), 127.6, 122.6, 122.4, 121.6, 116.5, 
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114.7 (2C), 41.2 (2C); Anal. Calcd for C15H17Cl2N3S: C, 52.63; H, 5.01; N, 12.27; Cl, 20.71; Found: C, 
52.60; H, 4.97; N, 12.23; Cl, 20.80. 
 
6-Amino-2-(3-fluorophenyl)benzothiazole monohydrochloride (17). Yield: 96.1%; mp 206-207 °C; IR 
cm-1: 2806, 2589, 1585, 1514, 1265, 848, 787; 1H-NMR (DMSO-d6) δ: 8.06 (d, 1H, J = 8.6 Hz), 7.99 
(s, 1H), 7.89-7.83 (m, 2H), 7.60 (dd, 1H, J = 7.3 Hz, J = 7.0 Hz), 7.44-7.38 (m, 2H), 3.95 (br s, 3H); 
13C-NMR (DMSO-d6) δ: 166.1, 162.4 (d, J = 245 Hz), 151.5, 135.5, 134.7 (d, J = 8.2 Hz), 132.0, 
131.6 (d, J = 8.3 Hz), 123.8, 123.4 (d, J = 2.6 Hz), 121.4, 118.2 (d, J = 21.0 Hz), 115.4, 113.4 (d, J = 
22.4 Hz); Anal. Calcd for C13H10ClFN2S: C, 55.62; H, 3.60; N, 9.98; Cl, 12.63; Found: C, 55.43; H, 
3.56; N, 9.79; Cl, 12.81. 
 
6-Amino-2-(4-fluorophenyl)benzothiazole monohydrochloride (19). Yield: 91.3%; mp 245-247 °C; IR 
cm-1: 3058, 2854, 2586, 1602, 1488, 1237, 839, 816; 1H-NMR (DMSO-d6) δ: 8.13 (dd, 2H, J = 5.6 Hz, 
J = 8.3 Hz), 8.06 (d, 1H, J = 8.6 Hz), 7.97 (s, 1H), 7.45-7.37 (m, 3H), 3.63 (br s); 13C-NMR (DMSO-
d6) δ: 166.7, 163.9 (d, J = 245 Hz), 151.8, 135.5, 131.0, 129.5 (d, J = 8.9 Hz, 2C), 129.1, 123.6, 121.1, 
116.5 (d, J = 22.2 Hz, 2C), 115.3; Anal. Calcd for C13H10ClFN2S: C, 55.62; H, 3.60; N, 9.98; Cl, 12.63; 
Found: C, 55.45; H, 3.56; N, 9.87; Cl, 12.78. 
 
Procedure D: The amines 7-12 (0.005 mol) were dissolved in a warm mixture of ethanol and 
xylene (1:1, v/v). A stream of dry hydrogen chloride was passed through the solution for 1 h while 
cooling to room temperature. The contents were then stirred in a stoppered flask for 2 h. The 
precipitated pure crystals were collected by filtration, washed with dry ether, and dried in vacuo. The 
following compound was prepared by this method: 
 
6-Amino-2-(3-fluorophenyl)benzothiazole dihydrochloride (18). Yield: 97.2%; mp 209-210 °C; IR 
cm-1: 3045, 2798, 2590, 2541, 1588, 1486, 861, 795; 1H-NMR (DMSO-d6) δ: 8.17-8.14 (m, 2H), 7.94-
7.88 (m, 2H), 7.64 (dd, 1H, J = 7.6 Hz, J = 6.3 Hz), 7.53 (d, 1H, J = 8.6 Hz), 7.46 (m, 1H), 4.45 (br s); 
13C-NMR (DMSO-d6) δ: 167.2, 162.4 (d, J = 244 Hz), 152.4, 135.3, 134.6 (d, J = 8.2 Hz), 131.6 (d, J 
= 8.4 Hz), 129.7, 123.8, 123.6, 122.3, 118.4 (d, J = 20.9 Hz), 117.2, 113.5 (d, J = 21.4 Hz); Anal. 
Calcd for C13H11Cl2FN2S: C, 49.22; H, 3.50; N, 8.83; Cl, 22.35; Found: C, 49.45; H, 3.50; N, 8.98; Cl, 
22.30. 
 
Cell culture 
 
Five different human cell lines were used for cytotoxicity screening: colon adenocarcinoma (CaCo-
2), cervical adenocarcinoma (HeLa), laryngeal carcinoma (Hep-2), mammary adenocarcinoma 
(MCF7), lung fibroblast (WI-38). Cells were seeded in tissue culture flasks (Sarstedt, Numbrecht, 
Germany) in Dulbecco's Modified Eagle medium (DMEM) (Gibco, Paisley, Scotland) supplemented 
with 10% foetal bovine serum (FBS; Gibco), 2 mM glutamine, 100 U/mL penicillin, and 100 µg/mL 
streptomycin in a humidified atmosphere with 5% CO2 at 37 °C. The cultures were passaged at 
preconfluent densities with the use of 0.025% trypsin (Institute of Immunology, Zagreb, Croatia). 
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Cytotoxicity assays 
 
For the experiments the cells were seeded onto 96-well microtiter plates at a density of 2 x 103 
cells per well and allowed to adhere for 24 h before the benzothiazoles were added over a 
concentration range of 1-100 µM. Stock solutions of benzothiazoles were dissolved in DMSO (Sigma, 
Deisenhofen, Germany) at the concentration of 0.1 M and were diluted with medium without bovine 
calf serum. The DMSO concentration was adjusted to be the same in test and control plates (1%). All 
drug solutions were freshly prepared on the day of testing. After incubation with benzothiazoles for 72 
h, cell growth was established according to the results of MTT assay [10] - Sigma, Deisenhofen, 
Germany. Each experiment was made in quadruplicate and repeated three times. The absorbency was 
measured on a microplate reader at 570 nm. (Labsystems, Finland) The percentage of growth (PG) of 
the cell lines was calculated according to the following expression: 
 [(Ti - Tz) / (C - Tz)] x 100 for concentrations for which Ti > / = Tz % 
where mean Tz = the average of optical density measurements before exposure of cells to the test 
compound, mean Ti = the average of optical density measurements after the desired period of time, 
and mean C = the average of optical density measurements after the desired period of time with no 
exposure of cells to the test compound. The results are expressed as IC50, which is the concentration 
necessary for 50% inhibition. The IC50 values for each compound are calculated from dose response 
curves using linear regression analysis by fitting the test concentrations that give PG values above and 
below the reference value (i.e. 50%). Each result is a mean of IC50 ± SD value from three separate 
experiments. 
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